"I've spent my professional life working on advancing the treatment of multiple sclerosis and am thrilled to be joining the talented and dedicated team at ...
The figure, closely watched by analysts, was boosted by an 11% increase in revenue to $300 million, helped by increased sales of multiple sclerosis drug ...
The study does not involve treatment. The MS Society of Canada describes multiple sclerosis as "... a complex disease. While it is most often diagnosed in ...
Biogen IDEC, Inc. (BIIB) – The world's largest producer of medication used in the treatment of multiple sclerosis posted a 48% increase in fourth-quarter ...
Some examples are vaccines, blood components, and most recently the recombinant proteins used to treat multiple sclerosis (MS) and other disorders. ...
... the marketing and distribution contract for the oral drug laquinimod, which is developed for treatment of relapsing-remitting multiple sclerosis (RRMS). ...
...multiple sclerosis (MS) drug Tysabri on February 5, 2010. An advisory sent by the FDA to patients and medical professionals warned that treatment with ...
The nurses were followed for 16 years, and 199 of them developed multiple sclerosis (MS) during that time period. "The risk of MS among daughters whose ...
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about the options by talking to a ...
Email this story
